Genmab A (GMAB) Change in Intangibles (2023 - 2025)

Genmab A has reported Change in Intangibles for 3 years, with the latest figure at -$18.0 million in Q3 2025.

• For the quarter ending Q3 2025, Change in Intangibles fell 800.0% year-over-year to -$18.0 million; the trailing twelve-month figure through Sep 2025 stood at -$71.0 million (changed N/A YoY), and the FY2025 full-year result was -$18.0 million, down 5.88% from the prior year.
• Change in Intangibles for Q3 2025 stood at -$18.0 million, roughly flat from -$18.0 million in the prior quarter.
• The five-year high for Change in Intangibles was -$1.0 million in Q4 2023, with the low at -$18.0 million in Q1 2025.
• Historically, Change in Intangibles has averaged -$12.3 million across 3 years, with a median of -$17.5 million in 2024.
• Annual changes were most pronounced in 2024 — Change in Intangibles plunged 1600.0% — and 2025, when it plunged 800.0%.
• Genmab A's Change in Intangibles stood at -$1.0 million in 2023, then sank by 1600.0% to -$17.0 million in 2024, then slipped by 5.88% to -$18.0 million in 2025.
• The last three Change in Intangibles figures came in at -$18.0 million (Q3 2025), -$18.0 million (Q2 2025), and -$18.0 million (Q1 2025), per Business Quant data.